Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma
- PMID: 30194842
- PMCID: PMC11327379
- DOI: 10.1002/lary.27268
Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma
Abstract
Objectives/hypothesis: With positron emission tomography/computed tomography (PET/CT) now commonplace as a diagnostic tool, new questions have arisen regarding the utility and cost-effectiveness of panendoscopy. In this retrospective review of a large cohort of head and neck squamous cell carcinoma of unknown primary (HNSCC-UP), we describe the enduring utility of panendoscopy in the detection of the primary site of mucosal disease even when PET/CT is negative.
Study design: Retrospective cohort study.
Methods: A retrospective analysis of patients presenting to the senior author (y.d.) from July 1 1997 to July 1 2017 with fine-needle aspiration-proven metastatic squamous cell carcinoma to the neck. All patients underwent formal panendoscopy (direct laryngoscopy, bronchoscopy, and rigid esophagoscopy). Presence of squamous cell carcinoma on final pathology was examined.
Results: A total of 190 patients had HNSCC-UP, with 87 positive and 103 negative on PET/CT. Of the PET/CT-negative patients, 71 patients retained the HNSCC-UP designation after panendoscopy. Eighteen patients (56% of cases) were found to have primary tonsillar squamous cell carcinoma. Eight of 32 primary sites were found in the base of tongue (25%), with HPV positivity in two of these patients. The sensitivity and negative predictive value of PET/CT in detecting the primary site in unknown primary head and neck squamous cell carcinoma in the total study population were 73.1% and 68.9%, respectively.
Conclusions: Surgical panendoscopy has an important role in the workup of patients with unknown primary head and neck squamous cell carcinoma. There is a high rate of cancer diagnosis, even in PET/CT negative patients.
Level of evidence: 4 Laryngoscope, 2573-2575, 2018.
Keywords: Unknown primary; negative positron emission tomography; panendoscopy.
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest
Comment in
-
In reference to combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.Laryngoscope. 2019 Apr;129(4):E122. doi: 10.1002/lary.27692. Epub 2018 Dec 14. Laryngoscope. 2019. PMID: 30549274 No abstract available.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. - PubMed
-
- Dong M-J, Zhao K, Lin X-T, Zhao J, Ruan L-X, Liu Z-F. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature. Nucl Med Commun. 2008. Sep;29(9):791–802. - PubMed
-
- Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. American Medical Association; 2005. Jul;131(7):626–9. - PubMed
-
- Haas I, Hoffmann TK, Engers R, Ganzer U. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). European Archives of Oto-Rhino-Laryngology. 2002. Jul;259(6):325–33. - PubMed
-
- Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017. Mar;67(2):122–37. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
